Robert J. Schott - Feb 12, 2022 Form 4 Insider Report for SANGAMO THERAPEUTICS, INC (SGMO)

Signature
Robert J. Schott, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
SGMO
Transactions as of
Feb 12, 2022
Transactions value $
-$31,467
Form type
4
Date filed
2/24/2022, 04:32 PM
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMO Common Stock Tax liability -$31.5K -5.46K -13.66% $5.76 34.5K Feb 12, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on February 12, 2022 which were surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on February 11, 2022 of $5.76/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP").
F2 Includes 7,869 shares resulting from the February 12, 2022 vesting of the Reporting Person's February 12, 2021 RSU grant and 26,668 shares subject to such RSU grant that will vest in two remaining annual installments of 13,332 shares and 13,336 shares on February 12, 2023 and 2024, respectively. The vesting of all such RSUs is subject to the Reporting Person's continuous service as defined in the Issuer's 2018 EIP through such dates and subject to acceleration as defined in the 2018 EIP.